Predictive items of one-year mortality in nonagenarians. The NonaSantfeliu Study

Formiga, Francesç; Ferrer, Assumpta; Mascaró, Joan; Ruiz, Domingo; Olmedo, Claudia; Pujol, Ramón

doi:10.1007/bf03324700

Cited by 40 publications

(40 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Not only is this rate lower than the intraoperative death rates for the younger age groups, it is also lower than the previously reported intraoperative mortality rates of 2.1%-6.4% for nonagenarian THA patients [3,5,6]. The one-year mortality rate of 5.5% among the nonagenarians of this study is less than a third of the 19.3% rate reported in a recent study following nonagenarian mortality [12]. Nonagenarians undergoing THA may be more likely to be closely followed by medical professionals and more likely to be receiving appropriate medical attention.…”

Section: Discussioncontrasting

confidence: 69%

Are Nonagenarians Too Old For Total Hip Arthroplasty? An Evaluation of Morbidity and Mortality Within a Total Joint Replacement Registry

Miric

Inacio

Kelly

et al. 2015

The Journal of Arthroplasty

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 69%

Are Nonagenarians Too Old For Total Hip Arthroplasty? An Evaluation of Morbidity and Mortality Within a Total Joint Replacement Registry

Miric

Inacio

Kelly

et al. 2015

The Journal of Arthroplasty

View full text Add to dashboard Cite

“…A diferencia de los resultados obtenidos en població n similar 10,11 , los resultados de este estudio sí que muestran que la historia de CI al inicio del estudio es un factor predictor relacionado con aumento de mortalidad global, lo que puede ser debido a que en el presente estudio, la historia cardiaca previa era má s comú n en los sujetos con PAS menor que 130 mmHg que en aquellos con PAS superiores. Respecto a la edad y la funcionalidad parece ló gico hallar que las personas de mayor edad y peor funcionalidad fallezcan má s, al ser la discapacidad uno de los síndromes geriá tricos de aparició n tardía y expresió n de otras comorbilidades, como ya habíamos comprobado que ocurría en los pacientes nonagenarios 20,21 .…”

Section: Tablaunclassified

Relación entre presión arterial y mortalidad a los 4 años de seguimiento en una cohorte de individuos mayores de 80 años

et al. 2011

View full text Add to dashboard Cite

“…4,5 In Italy it is estimated that in 2050 life expectancy for 65-year-old people will be about 30 years more 6 and we know that CHF is a predictor of mortality also in the elderly and very elderly patients. 7 Until a few years ago epidemiological data on CHF came from observational or registry studies in settings of Cardiology Departments. [8][9][10][11] The characteristics of these patients in many ways are similar to those of the HF trials designed for younger subjects without comorbidities.…”

Section: Introductionmentioning

confidence: 99%

The heart failure in Internal Medicine in Tuscany: the SMIT Study

Verdiani

Panigada²,

Fortini³

et al. 2015

Ital J Med

View full text Add to dashboard Cite

The incidence and prevalence associated with the growing age of population have made heart failure (HF) a new epidemic. In Italy most of HF patients are admitted to Internal Medicine Departments (IMD). We conducted a 30-day cross-sectional study involving patients with HF admitted to IMD of Tuscany. The aim of the study was to provide an updated snapshot of in-hospital management of HF in Tuscany and to analyze the differences in relation to the most recent guidelines. We have recruited 770 patients (M=45.4%) with a mean age of 82.5±8.9 years. Only 16.1% had a de novo HF. Most of them were re-admitted for decompensated HF. Hypertension and ischemic disease are the prevailing etiologies. HF alone was in less than 2%. 71.5% of patients had more than two comorbidities and 40.6% more than three concomitant diseases. The mean hospital stay (overall 8.6±5.5 days) correlated with the number of comorbidity. About 25% of patients had a creatinine clearance <30 mL/min. Nearly 50% of patients had atrial fibrillation but only the half was anti-coagulated. b-blockers, angiotensin converting enzyme-inhibitors (ACE-I) or angiotensin receptor blockers (ARB) were prescribed in about two-thirds of the subjects. Echocardiography was performed in 64.1% of patients. BNP or NT-pro BNP was tested in 67% at the hospital admission and in 18.3% at the discharge. At the discharge 50.1% of patients had loss of autonomy, 57% a polypharmacy prescription (≥8 classes of medicines) and 21.2% needed domiciliary oxygen therapy, but despite these critical points only 8% of the patients were transferred to long-term/intermediate care settings. In conclusion, the main characteristics of patients with HF admitted to IMD in Tuscany are the advanced age (the patients are old and very old) and the presence of multiple comorbidities (HF alone is a rarity indeed). The use of echocardiography and the pharmacological therapy with ACE-I, ARB, b-blocker and anti-aldosterone agents is wider than previous surveys, but some diagnostic, therapeutic and prognostic aspects are not similar to that recommended by the most recent HF guidelines. This survey underscores again some differences between HF trials world and HF real world, where the management is probably also driven by a clinical holistic approach. Correspondence: Valerio Verdiani, via Faccioli 15, 50145 Firenze, Italy. Tel.: +39.366.6581380 -Fax: +39.0564.48533. E-mail: verdiani@fastwebnet This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).

show abstract

Predictive items of one-year mortality in nonagenarians. The NonaSantfeliu Study

Abstract: This study supported the importance of age, heart failure and nutritional status in predicting 1- year mortality in nonagenarians.

Cited by 40 publications

References 22 publications

Are Nonagenarians Too Old For Total Hip Arthroplasty? An Evaluation of Morbidity and Mortality Within a Total Joint Replacement Registry

Are Nonagenarians Too Old For Total Hip Arthroplasty? An Evaluation of Morbidity and Mortality Within a Total Joint Replacement Registry

Relación entre presión arterial y mortalidad a los 4 años de seguimiento en una cohorte de individuos mayores de 80 años

The heart failure in Internal Medicine in Tuscany: the SMIT Study

Contact Info

Product

Resources

About